scholarly journals Resistance Exercise Reduces the Necessity for Hypoglycemic Agent (Humulin) in Overweight Women with Gestational Diabetes Mellitus

2021 ◽  
pp. 325-333
Author(s):  
P. Selvi ◽  
V. Manivannan ◽  
G. Liji Martina ◽  
V. Senbagavalli ◽  
C. Selvin Thanuja ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Gestational Diabetes ◽  
Gestational Diabetes Mellitus ◽  
Resistance Exercise ◽  
Strength Training ◽  
Blood Sugar ◽  
Overweight Women ◽  
Hypoglycemic Agent ◽  
Hypoglycaemic Agent ◽  
Agent Medical

Background: Gestational Diabetes Mellitus (GDM) is currently treated with blood sugar monitoring, nutritional supplements, increased fatal police work, and hypoglycemic agent medical help PRN to achieve and maintain normoglycemia. Even though humulin therapy has been demonstrated to reduce low birth weight in women with GDM, using hypoglycemic drugs is likely challenging and may not address peripheral hypoglycemic agent resistance, which is a critical role in the development of GDM. Furthermore, the use of aggressive low blood sugar medication therapy may result in a twofold rise in the amount of small-for-gestational-age infants. The resistance exercise was used in overweight women with Gestational Diabetes Mellitus. Because resistance exercise increase the lean body muscle or decrease the body fat and Resistance exercise is an effective glycaemic management and cardio metabolic health strategy. Methods: Fifteen patients with physiological condition DM were arbitrarily assigned whether it's to a group that received strength training or to a group that did not receive strength training to scale back the necessity for the hypoglycaemic agent. Results: Despite therapy, the number of girls who required hypoglycemic agent medical care has been the same. However, a meta-analysis with only overweight girls (pre-pregnancy BMI) revealed that the exercise cluster used to have a lower rate of hypoglycemic medication use (P<05) than that of the non-exercise receiving patients. Conclusion: Resistance exercise coaching might facilitate to avoid hypoglycaemic agent medical aid for pregnant overweight girls with physiological state diabetes

scholarly journals The Effect of Oat Bran Supplement on Fasting Blood Sugar and Glycosylated Hemoglobin in Patients with Gestational Diabetes Mellitus: Single-blind Randomized Clinical Trial

2019 ◽  
Author(s):  
Maedeh Shahzeidi ◽  
Azadeh Nadjarzadeh ◽  
Masoud Rahmanian ◽  
Amin Salehi Abarghuoei ◽  
Hossein Fallahzadeh ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Clinical Trial ◽  
Weight Gain ◽  
Gestational Diabetes ◽  
Gestational Diabetes Mellitus ◽  
Blood Sugar ◽  
Glycosylated Hemoglobin ◽  
Oat Bran ◽  
Single Blind ◽  
Hba1c Levels

Background: Gestational diabetes mellitus (GDM) is known as a degree of glucose intolerance that occurs for the first time during pregnancy. There is paucity of evidence regarding the effect of oat bran on GDM. Oat as a source of β-glucan can be effective in reducing the blood sugar levels. This study aimed to investigate the effect of oat bran on fasting blood sugar (FBS) and glycosylated hemoglobin (HbA1c) in patients with GDM. Method: This single-blind clinical trial was conducted on 90 pregnant women with GDM. The experimental group (EG) consumed 30 g of oat bran daily with 100 g of low-fat yogurt before lunch and dinner for 4 weeks. The control group (CG) consumed only low-fat yogurt and both groups received nutrition counseling. The present study investigated the FBS, HbA1c, and weight gain at the beginning and after four weeks of intervention. Results: Out of 90 patients, 80 completed the study. FBS decreased in the EG (P = 0.04, -2.75 ± 8.22), whereas, it increased in the CG (P = 0.003, 4.37 ± 8.72). No significant difference was observed between the two groups in terms of HbA1c levels. Weight gain was controlled more efficiently in the EG than the CG (P = 0.001). Conclusion: The use of oat bran for four weeks decreased the FBS,; whereas, it did not affect HbA1c levels. Weight gain was controlled better in the EG than the CG.

scholarly journals Oral Hypoglycemic Glibenclamide: Can it be a Substitute to Insulin in the Management of Gestational Diabetes Mellitus? A Comparative Study

2012 ◽  
Vol 4 (1) ◽  
pp. 28-31 ◽  
Author(s):  
Partha Mukhopadhyay ◽  
Tara Sankar Bag ◽  
Amit Kyal ◽  
Dipta Prasun Saha ◽  
Noori Khalid
Keyword(s):  
Diabetes Mellitus ◽  
Blood Glucose ◽  
Birth Weight ◽  
Glycemic Control ◽  
Gestational Diabetes ◽  
Gestational Diabetes Mellitus ◽  
Comparative Study ◽  
Blood Sugar ◽  
Group A ◽  
Group B

ABSTRACT Introduction Gestational diabetes is a common medical disorder in pregnancy. So long, it has been usually treated by insulin. Now it has been found that oral glibenclamide can be used instead of insulin with similar glycemic control and without any adverse maternal and fetal effect. Methods A comparative study between oral glibenclamide and insulin for the management of gestational diabetes mellitus (GDM) was conducted. It was a prospective randomized study and patients attending the antenatal clinic were screened with 75 gm oral glucose between 20 to 28 weeks and GDM was diagnosed based on WHO criteria of 2 hours blood glucose ≥140 mg/dl. Women with gestational diabetes were given medical nutritional therapy (MNT) for 2 weeks. Out of this, 60 women did not achieve the target blood glucose. The goal of treatment was maintenance of mean plasma glucose (MPG) of about 105 mg%. For this the fasting plasma glucose should be around 90 mg/dl and postprandial peaks around 120 mg/dl. Patients were randomly assigned to receive glibenclamide (group A, n = 30) or insulin (group B, n = 30). In group A, glibenclamide was given 2.5 mg orally in morning and doses were increased weekly by 2.5 mg up to a maximum of 20 mg and doses >7.5 mg were given in two divided doses. In group B, insulin 0.7 units per kilogram of body weight at admission was given subcutaneously three times daily and increased weekly as necessary. Self monitoring of blood glucose with glucometer was done. Blood glucose was also measured from the laboratory every week. Glycosylated hemoglobin (HbA1c) was measured before initiation of therapy and repeated in the third trimester before confinement. Terminations of pregnancy in both the groups were done between 37 and 38 weeks. The infant birth weight, blood glucose and serum bilirubin were also recorded in all cases. Results The present study showed that the two groups had similar glycemic status (fasting blood sugar in group A was 103.5 ± 14.62 mg/dl and postprandial blood sugar was 184.1 ± 20.46 mg/dl whereas in group B it was109.3 ± 19.63 mg/dl and 194.3 ± 18.47mg/dl) at the time of entry into the study. The two groups also showed similar levels of glycemic control just before confinement (fasting blood sugar in group A was 88.23 ± 6.55 mg/ dl and postprandial blood sugar was 122.7 ± 10.3 mg/dl whereas in group B it was 88.17 ± mg/dl and 128 ± 12.38 mg/dl) and there was no significant statistical difference in the two groups (p > 0.05). The perinatal outcomes in both the groups were also nearly same. There was no significant difference in birth weight, blood sugar level of neonates and complications between the two groups. There was no case of macrosomia in the two groups and the number of infants large for gestational age (LGA) was four in group A and two in group B. Hypoglycemia in newborn was slightly higher in the group A compared to group B (4 and 3 respectively). Conclusion From our study, it is evident that the use of oral agents is a pragmatic alternative to insulin therapy in cases of gestational diabetes because of similar glycemic control, ease of administration and better patient compliance due to noninvasive treatment. How to cite this article Mukhopadhyay P, Bag TS, Kyal A, Saha DP, Khalid N. Oral Hypoglycemic Glibenclamide: Can it be a Substitute to Insulin in the Management of Gestational Diabetes Mellitus? A Comparative Study. J South Asian Feder Obst Gynae 2012;4(1):28-31.

Diet Control in Pregnant Women with Gestational Diabetes Mellitus

2019 ◽  
Vol 15 (4) ◽  
pp. 245-250
Author(s):  
Piyaporn Sitkulanan ◽  
Natthananporn Sanguanklin ◽  
Sirikhwan Pomjumpa
Keyword(s):  
Diabetes Mellitus ◽  
Gestational Diabetes ◽  
Gestational Diabetes Mellitus ◽  
Pregnant Women ◽  
Blood Sugar ◽  
Type Ii Diabetes Mellitus ◽  
Negative Consequences ◽  
Normal Range ◽  
Diet Control ◽  
Sugar Levels

Background: The incidence of diabetes mellitus has significantly increased in the last two decades. Gestational diabetes mellitus, GDM, is a complication that affects both pregnant women and newborn babies. Pregnant women that are diagnosed with GDM are 7 times more likely to be diagnosed with type II diabetes mellitus. In addition, infants born by GDM mothers are at higher risk of developing diabetes mellitus in the future. Objective: The study aims to review the literature on the diet control in pregnant women with gestational diabetes mellitus. Results: Controlling blood sugar within the normal range during pregnancy can decrease negative pregnancy outcomes. However, most pregnant women with GDM cannot control their blood sugar within the normal range because of a lack of knowledge and skill in selecting appropriate foods. They also often experience inconsistency in their diet control behavior Most pregnant women worry about gaining too much weight, and most pregnant women with GDM have to learn how to choose their food properly in terms of both nutrients and quantity in order to control their blood sugar levels within the normal range. Conclusion: Diet control during pregnancy is one way to prevent the negative consequences of GDM for both mothers and infants. The food proportion for pregnant women with gestational diabetes is CHO: PRO: FAT = 50: 20:30 and also to consume an appropriate amount of vitamins and minerals and water each day.

scholarly journals A comparative study of ADA and WHO criteria for screening of gestational diabetes mellitus

2018 ◽  
Vol 7 (3) ◽  
pp. 957
Author(s):  
Jeyamani Baskaran ◽  
Subha Sivagami Sengodan ◽  
Anbarasi Pandian
Keyword(s):  
Diabetes Mellitus ◽  
Gestational Diabetes ◽  
Gestational Diabetes Mellitus ◽  
Comparative Study ◽  
Blood Sugar ◽  
Universal Screening ◽  
Statistical Significance ◽  
Fasting Blood Glucose ◽  
Fasting Blood Sugar ◽  
Who Criteria

Background: Gestational diabetes mellitus is defined as carbohydrate intolerance with its onset or first recognition during present pregnancy. Objective of present study was to compare screening accuracy of ADA and WHO criteria for screening of gestational DM.Methods: This is a prospective comparative study using ADA and WHO criteria for the screening of GDM. Our objective was to study the implication of implementing the ADA guidelines and WHO guidelines for screening and diagnosis of GDM in 200 antenatal patients at Government Mohankumaramangalam Medical College, Salem during a period of one year from July 2015 to June 2016. All antenatal women attending AN OP between 24-28 weeks of gestation are subjected to fasting blood glucose measurement followed by an oral OGTT using 75 gms of glucose load. Venous blood samples are collected at the end of 1hr and 2hr. The ADA and WHO criteria were applied separately for each subject to diagnose GDMResults: As per ADA criteria presence of any one of either, Fasting blood sugar- 92 mg (5.1 mmol/L),1 hour postprandial-180mg (10.00mmol/L), 2 hour postprandial: 153 mg (8.5 mmol/L) was used for the diagnosis of GDM.As per WHO criteria presence of any one of either, Fasting blood sugar- 126mg/dl (7 mmol/dl) or 2 hour postprandial- 140 mg/dl (7.8 mmol/dl) for diagnosis of GDM. The 2hr value has the statistical significance in the diagnosis of GDM. The 1hr value done in ADA criteria does not have statistical significance when compared to 2hr value.Conclusions: Universal screening for GDM is necessary to diagnose Gestational Diabetes Mellitus. Universal screening may not be feasible in resource poor settings, but it definitely improves the pregnancy outcomes considering the high prevalence of gestational diabetes in India.

Adipokine levels in overweight women with early-onset gestational diabetes mellitus

2018 ◽  
Vol 42 (2) ◽  
pp. 149-156 ◽  
Author(s):  
T. F. Lobo ◽  
M. R. Torloni ◽  
R. Mattar ◽  
M. U. Nakamura ◽  
S. M. Alexandre ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Gestational Diabetes ◽  
Gestational Diabetes Mellitus ◽  
Early Onset ◽  
Overweight Women
Sign in / Sign up

Export Citation Format

Share Document